These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 6757466

  • 1. Immunoperoxidase staining of acid phosphatase in human prostatic tissue.
    Lippert MC, Bensimon H, Javadpour N.
    J Urol; 1982 Nov; 128(5):1114-6. PubMed ID: 6757466
    [Abstract] [Full Text] [Related]

  • 2. Transitional cell carcinoma of the prostate.
    Algaba F, Santaularia JM, Lamas M, Ayala G.
    Eur Urol; 1985 Nov; 11(2):87-90. PubMed ID: 3891355
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI, Eggleston JC.
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [Abstract] [Full Text] [Related]

  • 9. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
    Heyderman E, Brown BM, Richardson TC.
    J Clin Pathol; 1984 Dec; 37(12):1363-9. PubMed ID: 6392348
    [Abstract] [Full Text] [Related]

  • 10. Immunoperoxidase localization of prostatic acid phosphatase in prostatic carcinoma with sarcomatoid changes.
    Ordoñez NG, Ayala AG, von Eschenbach AC, Mackay B, Hanssen G.
    Urology; 1982 Feb; 19(2):210-4. PubMed ID: 7036494
    [Abstract] [Full Text] [Related]

  • 11. An immunoperoxidase technique to aid in the differential diagnosis of prostatic carcinoma.
    Fishleder A, Tubbs RR, Levin HS.
    Cleve Clin Q; 1981 Feb; 48(3):331-5. PubMed ID: 7028321
    [Abstract] [Full Text] [Related]

  • 12. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
    Koh E, Sekii K, Namiki M, Fujioka H, Onoue K, Sakurai M, Sonoda T.
    Eur Urol; 1987 Feb; 13(1-2):142-4. PubMed ID: 2438138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunoperoxidase demonstration of prostatic acid phosphatase in aspiration biopsy cytology (ABC).
    Keshgegian AA, Kline TS.
    Am J Clin Pathol; 1984 Nov; 82(5):586-9. PubMed ID: 6388312
    [Abstract] [Full Text] [Related]

  • 16. Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
    Yam LT, Winkler CF, Janckila AJ, Li CY, Lam KW.
    Cancer; 1983 Jan 15; 51(2):283-7. PubMed ID: 6336978
    [Abstract] [Full Text] [Related]

  • 17. Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.
    Epstein JI, Kuhajda FP, Lieberman PH.
    Hum Pathol; 1986 Sep 15; 17(9):939-42. PubMed ID: 2428729
    [Abstract] [Full Text] [Related]

  • 18. Prostatic mucinous adenocarcinoma.
    Hsueh Y, Tsung SH.
    Urology; 1984 Dec 15; 24(6):626-7. PubMed ID: 6095509
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.